Immunotherapy with Autologous Tregs in T1DM

NCT06708780 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: Ex vivo Expanded Human Autologous Regulatory T Cells
OTHER: Routine Care

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Collaborators

[object Object]